Will CMS Leave Labs to Fend for Themselves in Face of New Regulatory Costs?

According to a former chair of the Medicare Payment Advisory Commission and Medicare policy advisor, "the probability of CMS changing its reimbursement policy [in response to the regulatory reform] is not high."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.